The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

Hypertension improvement and when medication needs revisiting — a second dataset

This is a generated summary. It shows the 9 most-liked posts from a topic of 134, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
AI
a.iyerTL29 Oct 2024#10
k.batista, post #2: Where I part company with the opening post, and it is a narrow parting. The practical value of this subcategory is helping somebody frame the question they take to an appointment, and that is worth being explicit about. Go to post

That is consistent with mine, for whatever one more account is worth.

30 likes in reply to #2 22mo
K
KLindqvistTL4 Moderator13 Oct 2024#26

A condition that affects nutrition or absorption changes the calculus around a treatment that reduces intake, and that interaction is mostly unstudied.

27 likes 21mo
KK
k.kimaniTL216 Oct 2024#43
g.pemberton_uk, post #7: I would put moderate confidence on the mainstream reading of Hypertension improvement and no more. That is not scepticism for its own sake; it is where the sourcing actually stops. Go to post

Adding a data point of agreement rather than a data point.

32 likes in reply to #7 21mo
MA
m.adeyemiTL218 Oct 2024#58

Building on post #57 rather than restating it.

On Hypertension improvement, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.

29 likes 21mo
JP
j.palaciosTL219 Oct 2024#61
a.cardoso, post #20: This follows post #17 rather than contradicting it. Nothing here is medical advice and clinicians posting in this subcategory say so on their own account rather than because a rule requires it. This is the sort of thing the wiki should carry and currently does not. Go to post

Reading back through the Hypertension improvement threads from last year, the same three questions come up every time and only one of them has ever been answered properly. That seems like a documentation gap rather than a knowledge gap.

29 likes in reply to #20 21mo
MR
m.radichTL221 Oct 2024#75
ch.correia, post #71: Hypertension improvement would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator. Go to post

A note on scope: what I am saying about Hypertension improvement applies to the case in the first post and I would not extend it further without checking.

27 likes in reply to #71 21mo
W
WoodhouseTL2Member24 Oct 2024#93

The practical value of this subcategory is helping somebody frame the question they take to an appointment, and that is worth being explicit about.

32 likes 21mo
AK
an.kirchnerTL225 Oct 2024#100
a.vermeulen, post #65: The practical value of this subcategory is helping somebody frame the question they take to an appointment, and that is worth being explicit about. The interesting part of this is the exception, and I do not understand the exception. Go to post

Hypertension improvement has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.

33 likes in reply to #65 21mo
TD
t.duarteTL226 Oct 2024#106

Where two conditions pull in opposite directions, that is a clinical judgement rather than a lookup, and it is the kind of question a forum answers worst.

33 likes 21mo

Read the full topic (134 posts)

Suggested topics

TopicParticipantsRepliesViewsActivity
Hepatic steatosis: what the MASH trial evidence supports — one year on
On the subject in the title: Hepatic steatosis: what the MASH trial evidence supports — one year on Working notes rather than a conclusion. Reading back through what has been written here about Hepatic…
VVSMG 2 4.1k 6mo
Revisiting: PCOS and metabolic overlap: what is and is not studied
Revisiting: PCOS and metabolic overlap: what is and is not studied — setting out what I have, and where I think it stops being reliable. Trying to establish the boundary conditions on PCOS and metabolic…
FEMHRSOBKD+55 59 26k 2d
Second pass at: Obstructive sleep apnoea and a hard endpoint in this class
Second pass at: Obstructive sleep apnoea and a hard endpoint in this class — setting out what I have, and where I think it stops being reliable. Something about Obstructive sleep apnoea does not reconcile and…
SVCLRF 2 726 14mo
PCOS and metabolic overlap: what is and is not studied
On the subject in the title: PCOS and metabolic overlap: what is and is not studied Working notes rather than a conclusion. PCOS and metabolic overlap, from the point of view of someone who has read the…
SGPGBST 3 6.6k 1d
Type 2 diabetes and the largest part of the evidence base — does this still hold?
Type 2 diabetes and the largest part of the evidence base — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Trying to work out what would count…
NANKEML+18 25 1.7k 22mo

Related topics — sharing the tags blood pressure, type 2 diabetes, obstructive sleep apnoea

TopicParticipantsRepliesViewsActivity
Type 2 diabetes and the largest part of the evidence base
Posting this under the heading it deserves: Type 2 diabetes and the largest part of the evidence base Everything below is what sits behind that. Trying to work out what would count as evidence on type 2…
CNFNAISCJB+81 89 2.9k 3mo
[2026 update] Cardiovascular risk: reading the outcome trials as a set
Posting this under the heading it deserves: Cardiovascular risk: reading the outcome trials as a set Everything below is what sits behind that. I have spent a fortnight trying to pin Cardiovascular risk down…
SOAWKRLDNL+99 103 32k 11mo
Revisiting: Gallbladder disease risk with rapid weight loss
Revisiting: Gallbladder disease risk with rapid weight loss Writing it up because I had to work it out twice and would rather nobody else did. Two things I would like separated before anyone answers on…
BVSLN 2 2k 9mo
Heart failure with preserved ejection fraction: symptom endpoints
Heart failure with preserved ejection fraction: symptom endpoints — setting out what I have, and where I think it stops being reliable. Heart failure with preserved ejection keeps being re-asked here and I…
ITSGSRFVII+19 23 311 12d
How to ask for a dose change without antagonising anyone — what changed since
How to ask for a dose change without antagonising anyone — what changed since — that is the question, and I have not found it answered plainly anywhere I have looked. A question about how to describe…
RVHKTDESAA+81 92 10k 20mo